BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

R-Bridge Healthcare Fund Provides $40M Financing to Mirxes to Accelerate Global Expansion of Cancer Early Detection Solutions

R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and f...

January 14, 2025 | News

Aragen Secures $100 Mn Investment from Quadria Capital, Valued at $1.4 Bn

Aragen, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has secured a $100 Mn investment...

January 13, 2025 | News

Verismo Therapeutics Secures $4.05M Investment from IFLI to Advance SynKIR™-310 for Follicular Lymphoma

Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI). The partnership with...

January 08, 2025 | News

Brii Biosciences Gains Full Control of BRII-179 Intellectual Property in $18M Deal

Further secures Brii's rights in BRII-179 with full control of intellectual property, future manufacturing and supply Several combination treatment studie...

January 01, 2025 | News

BeiGene Exercises Exclusive Option for DualityBio's B7H4 ADC, Paving the Way for Global Development

Duality Biologics ("DualityBio") announced that, BeiGene. Ltd. has exercised its exclusive option for the B7H4 antibody-drug conjugate (ADC) DB1312/BG-C907...

December 31, 2024 | News

Exicure Signs MOU to Acquire GPCR USA and Advance Collaborative Research in Drug Development

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR ...

December 30, 2024 | News

New Therapeutics Venture GEMMABio Secures $34M in Seed Funding to Accelerate Gene Therapy Initiatives

Significant international investment defies sector trend GEMMA Biotherapeutics ("GEMMABio") – a new therapeutics company founded by gene therapy pio...

December 24, 2024 | News

PeproMene Bio Secures $11M Investment to Advance BAFF-R CAR T Therapy for Relapsed Follicular Lymphoma

Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive $6M USD upfront plus an addit...

December 20, 2024 | News

Ayala Corporation Secures €50 Million Social Loan from ING to Boost Philippine Healthcare Initiatives

Ayala Corporation signed a €50 million (₱3.1 Billion) social loan from leading European bank ING to support AC Health's portfolio growth. Key...

December 19, 2024 | News

South Korea invests in Generate Biomedicines through Samsung to drive global biopharma innovation.

Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics disc...

December 18, 2024 | News

Australia’s Cartherics Secures $300K G-Rex Grant to Advance Manufacturing of Allo CAR-iNK Cells for Ovarian Cancer Trials

- Cartherics has received a US$300K G-Rex grant to support its ‘in house’ manufacturing program- Funding will enable Cartherics to generate cru...

December 18, 2024 | News

Novo Holdings Completes Catalent Acquisition; Novo Nordisk Secures Strategic Manufacturing Sites

Analysis of Novo Holdings A/S’s Acquisition of Catalent and Novo Nordisk’s Strategic Expansion The imminent completion of ...

December 16, 2024 | Analysis

Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production

The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity&nb...

December 06, 2024 | News

Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies

Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...

November 29, 2024 | News

Stay Connected